IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comanducci, M.
Right arrow Articles by Pizza, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comanducci, M.
Right arrow Articles by Pizza, M.

 Previous Article  |  Next Article 

Infection and Immunity, July 2004, p. 4217-4223, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4217-4223.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

NadA Diversity and Carriage in Neisseria meningitidis

Maurizio Comanducci,1 Stefania Bambini,1 Dominique A. Caugant,2 Marirosa Mora,1 Brunella Brunelli,1 Barbara Capecchi,1 Laura Ciucchi,1 Rino Rappuoli,1* and Mariagrazia Pizza1

IRIS, Chiron Vaccines, 53100 Siena, Italy,1 WHO Collaborating Centre for Reference and Research on Meningococci, National Institute of Public Health, Nydalen, N-0403 Oslo, Norway2

Received 10 December 2003/ Returned for modification 15 January 2004/ Accepted 11 February 2004

NadA is a novel vaccine candidate recently identified in Neisseria meningitidis and involved in adhesion to host tissues. The nadA gene has been found in approximately 50% of the strains isolated from patients and in three of the four hypervirulent lineages of non-serogroup A strains. Here we investigated the presence of the nadA gene in 154 meningococcal strains isolated from healthy people (carrier strains). Only 25 (16.2%) of the 154 carrier isolates harbored the nadA gene. The commensal species Neisseria lactamica was also found not to have the nadA gene. Eighteen of the carrier strains belonged to the ET-5 and ET-37 hypervirulent clusters, indicating that only the 5.1% of the genuine carrier population actually harbored nadA (7 of 136 strains). Five of the seven strains harbored a novel allele of the nadA gene that was designated nadA4. The NadA4 protein was present on the bacterial surface as heat-stable high-molecular-weight oligomers. Antibodies against the recombinant NadA4 protein were bactericidal against homologous strains, whereas the activity against other NadA alleles was weak. In conclusion, the nadA gene segregates differently in the population of strains isolated from healthy individuals and in the population of strains isolated from patients. The presence of NadA can therefore be used as a tool to study the dynamics of meningococcal infections and understand why this bacterium, which is mostly a commensal, can become a severe pathogen.


* Corresponding author. Mailing address: IRIS, Chiron Vaccines, via Fiorentina 1, 53100 Siena, Italy. Phone: 39 577 24 3414. Fax: 39 577 24 3564. E-mail: rino_rappouli{at}chiron.com.

Editor: J. N. Weiser


Infection and Immunity, July 2004, p. 4217-4223, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4217-4223.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.